Precision Therapeutics Inc. (106) | Separation Agreements (2)
- Transition and Separation Agreement dated September 15, 2022 by and between J. Melville Engle and Predictive Oncology Inc (Filed With SEC on September 16, 2022)
- Transition and Separation Agreement by and between the Company and Carl Schwartz dated March 19, 2021 (Filed With SEC on March 23, 2021)
